Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review
Authors
Keywords
Schizophrenia, Mental health, Nutrition, Personalised medicine, Adjunct treatment
Journal
Nutrition Journal
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-09-16
DOI
10.1186/1475-2891-13-91
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial
- (2014) Francisco Romo-Nava et al. BIPOLAR DISORDERS
- Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study
- (2013) Casey Crump et al. AMERICAN JOURNAL OF PSYCHIATRY
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
- (2013) Mehdi Farokhnia et al. CLINICAL NEUROPHARMACOLOGY
- Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions
- (2013) Dieter Schoepf et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Psychiatric comorbidity among adults with schizophrenia: A latent class analysis
- (2013) Jack Tsai et al. PSYCHIATRY RESEARCH
- Randomized Multicenter Investigation of Folate Plus Vitamin B12Supplementation in Schizophrenia
- (2013) Joshua L. Roffman et al. JAMA Psychiatry
- Life expectancy and cardiovascular mortality in persons with schizophrenia
- (2012) Thomas M. Laursen et al. CURRENT OPINION IN PSYCHIATRY
- Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease
- (2012) Darryl W. Eyles et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects
- (2012) George Anderson et al. METABOLIC BRAIN DISEASE
- Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia
- (2012) Undurti N. Das PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Putative neuroprotective agents in neuropsychiatric disorders
- (2012) Seetal Dodd et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Serum Levels of Brain-Derived Neurotrophic Factor and Cortisol to Sulfate of Dehydroepiandrosterone Molar Ratio Associated With Clinical Response to l-Theanine as Augmentation of Antipsychotic Therapy in Schizophrenia and Schizoaffective Disorder Patients
- (2011) Chanoch Miodownik et al. CLINICAL NEUROPHARMACOLOGY
- A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia
- (2011) K. Akter et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Genetic Variation Throughout the Folate Metabolic Pathway Influences Negative Symptom Severity in Schizophrenia
- (2011) J. L. Roffman et al. SCHIZOPHRENIA BULLETIN
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33 000 women from the general population
- (2010) Maria Hedelin et al. BMC Psychiatry
- Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders
- (2010) Jeremy W. Gawryluk et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder
- (2010) Michael S. Ritsner et al. JOURNAL OF CLINICAL PSYCHIATRY
- Is it time to reassess alpha lipoic acid and niacinamide therapy in schizophrenia?
- (2010) Sheila E.J. Seybolt MEDICAL HYPOTHESES
- Oxidative stress in schizophrenia: An integrated approach
- (2010) Byron K.Y. Bitanihirwe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Developmental Vitamin D Deficiency and Risk of Schizophrenia: A 10-Year Update
- (2010) J. J. McGrath et al. SCHIZOPHRENIA BULLETIN
- A meta-analysis of oxidative stress markers in schizophrenia
- (2010) Ming Zhang et al. Science China-Life Sciences
- A Preliminary Investigation of α-Lipoic Acid Treatment of Antipsychotic Drug-Induced Weight Gain in Patients With Schizophrenia
- (2009) Eosu Kim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Prenatal Malnutrition and Adult Schizophrenia: Further Evidence From the 1959-1961 Chinese Famine
- (2009) Ming-Qing Xu et al. SCHIZOPHRENIA BULLETIN
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Novel immune response to gluten in individuals with schizophrenia
- (2009) Diana Samaroo et al. SCHIZOPHRENIA RESEARCH
- One-carbon metabolism and schizophrenia: current challenges and future directions
- (2009) M.O. Krebs et al. TRENDS IN MOLECULAR MEDICINE
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?
- (2007) Joyce C. McCann et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now